Farxiga (dapagliflozin) is a prescription drug, commonly taken as a 10 mg oral tablet once daily, to lower blood glucose levels in Type 2 diabetes mellitus, reduce the risk of hospitalization and cardiovascular death in congestive heart failure (CHF), and lower the risk of progression of chronic kidney disease (CKD)
However, clinical differences are small, and slow dose increases minimize nausea regardless of which drug you choose
Guide This guide gives insights into solutions to common challenges like cost volatility, lack of clinical coordination, inconsistent member experience, and prior authorization complexities
However, semaglutide remains highly effective and may be the better choice for certain patients
TRICARE Prime and Select beneficiaries remain eligible for GLP-1 coverage for weight-related medical conditions
doi:10.1177/17455057251384412